Evolent Health (EVH) Moves 12.8% Higher: Will This Strength Last?
Trending Stocks Today: Shimmick Surges 46.85% Post-Market
July 16th - US stocks trending post-market.Gainers: $Shimmick(SHIM.US)$ shoots up 46.85% to $3.04 with a turnover of $7.02 million. $Aehr Test Systems(AEHR.US)$ rises 12.64% to $18.97 with a
Investors Will Want Evolent Health's (NYSE:EVH) Growth In ROCE To Persist
Press Release: Evolent To Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024
Evolent To Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024 PR Newswire WASHINGTON, July 11, 2024 Company to Participate in Upcoming Conferences WASHINGTON, July 11, 2024 /
TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $63
TD Cowen analyst Charles Rhyee maintains $Evolent Health(EVH.US)$ with a buy rating, and maintains the target price at $63.According to TipRanks data, the analyst has a success rate of 46.7% and a
TD Cowen Sticks to Its Buy Rating for Evolent Health (EVH)
Evolent Health (EVH) Receives a Hold From Truist Financial
Evolent Health Falls To US$19.12, But Insiders Sold At Lower Price
Evolent Health, Inc.'s (NYSE:EVH) value has fallen 13% in the last week, but insiders who sold US$222k worth of stock over the last year have had less success. Insiders might have been better off hol
JMP Securities Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $34
JMP Securities analyst Constantine Davides maintains $Evolent Health(EVH.US)$ with a buy rating, and maintains the target price at $34.According to TipRanks data, the analyst has a success rate of 23.
Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE) and secondl
Express News | NYSE Order Imbalance 56214.0 Shares on Sell Side
RBC Capital Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $42
RBC Capital analyst Sean Dodge maintains $Evolent Health(EVH.US)$ with a buy rating, and maintains the target price at $42.According to TipRanks data, the analyst has a success rate of 39.8% and a tot
Truist Financial Maintains Evolent Health(EVH.US) With Hold Rating
Truist Financial analyst Jailendra Singh maintains $Evolent Health(EVH.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 29.9% and a total average return of -15.5%
Evolent Health To Acquire Machinify - Quick Facts
Express News | Evolent To Acquire Certain Assets Of Machinify And The Exclusive, Perpetual And Royalty-Free License Of Machinify Auth; Terms Not Disclosed
Express News | Evolent Health - Acquisition Is Immaterial to Evolent's Revenue Outlook and Is Estimated to Be Neutral to Adjusted Ebitda in First Year After Closing
Express News | Evolent Signs Agreement to Acquire Artificial Intelligence Utilization Management Products and Team From Machinify
Express News | NYSE Order Imbalance 82952.0 Shares on Buy Side
Shareholders Will Most Likely Find Evolent Health, Inc.'s (NYSE:EVH) CEO Compensation Acceptable
Express News | Evolent Health Inc : Guggenheim Cuts Target Price to $42 From $47